Under the patronage and honor of His Royal Highness Prince Saud bin Nayef bin Abdulaziz Al Saud, Governor of the Eastern Province - may God protect him -

On the sidelines of the Eastern Province Health Investment Forum 2026

Dhahran, Saudi Arabia, outperforming all hospitals in the Eastern Province, Johns Hopkins Aramco Healthcare (JHAH) announced its first-place win of the prestigious “Ameez” award presented by the Ministry of Health, which was presented under the generous patronage of His Royal Highness Prince Saud bin Nayef bin Abdulaziz Al Saud, Governor of the Eastern Province.

The award was presented during the Eastern Province Health Investment Forum in Dammam on April 7, coinciding with the celebration of World Health Day, in recognition of the center’s commitment to excellence in service, patient experience, and innovation in healthcare delivery.

The "Ameez" Award recognizes institutions that embody leadership and innovation in the healthcare sector, driving tangible improvements in patient safety and quality of care delivery. This is based on these institutions' forward-looking strategies, strong governance, and initiatives to enhance the patient experience and the quality of healthcare services in the Kingdom of Saudi Arabia.

Commenting on winning this prestigious award, Dr. Howard Podolsky, CEO of Johns Hopkins Aramco Healthcare, said: “Our recognition with the Ministry of Health’s ‘Ameez’ award, under royal patronage, embodies our unwavering commitment to quality care, patient safety, and innovation. It underscores the continuous and tireless efforts of our teams and the standards we uphold in our work every day. Our focus will remain on promoting community health and well-being and contributing to the realization of the Kingdom’s Vision 2030 goals.”

It is worth noting that this achievement is part of a series of strategic projects reflecting the center's commitment to developing specialized and integrated care throughout the Kingdom and reshaping the future of healthcare. Among the most prominent of these projects was the recent launch of the Center of Excellence in Cardiovascular Diseases, its second center of excellence after the Oncology Center, a move that solidifies comprehensive specialized services across the Kingdom. Furthermore, the center achieved its highest ranking to date, securing third place in the Kingdom on Newsweek magazine's list of the world's best hospitals for 2026, further cementing its position among leading healthcare institutions.

The ceremony was attended by several senior management members from Johns Hopkins Aramco Healthcare (JHAH), including Dr. Howard Podolsky; Dr. Russell Hills, President of Centers of Excellence; Dr. Mohammed Alghamdi, Executive Director for the Southern Region; and Willie Williamsey, President of Strategic Planning and Business Development.

About Johns Hopkins Aramco Healthcare (JHAH) :

The Johns Hopkins Aramco Healthcare (JHAH) is a leading healthcare provider, established in 2014 as a joint venture between Saudi Aramco and Johns Hopkins Medicine (JHM). This decade-long collaboration combines Saudi Aramco’s long-standing medical heritage, dating back to the Saudi Aramco Medical Services Organization (SAMSO) since 1945, with JHM’s global leadership in clinical medical innovation, advanced medical research, and distinguished education.

The center provides world-class, patient-centered healthcare across multiple specialties, including cardiovascular medicine, oncology, orthopedics, women’s health, pediatrics, mental health, neurology, and musculoskeletal care. It integrates innovative care models, such as telemedicine, home hospital services, and AI-enhanced diagnostics, to deliver comprehensive, accessible, and personalized care tailored to each patient’s needs. By pushing the boundaries of precision medicine, advancing digital innovation in healthcare, and developing a national pool of specialized talent, the center continues to meet the diverse needs of the communities it serves. Johns Hopkins Aramco Healthcare recently launched Centers of Excellence in Cardiovascular Medicine and Oncology, further enhancing its specialized care services.

For more information, please visit www.jhah.com and follow Johns Hopkins Aramco Healthcare on LinkedIn, Instagram, X platform, Facebook, and YouTube.

For media inquiries, please contact:

Mahmoud Abu Roub

Mahmoud.Abu-Rob@bursonglobal.com

-I finish-

#Company Data

Disclaimer regarding the content of press releases
The content of this press release is provided by a third-party provider. We do not assume any responsibility for, nor do we have any control over, such content. This content is provided on an "as is" and "as available" basis and is not edited in any way. Neither we, nor our affiliates, will be liable for the accuracy, endorsement, or completeness of any opinions, views, information, or materials contained in this content.
This press release is provided for informational purposes only; the content does not constitute legal, investment, or tax advice, nor does it offer any opinion on the suitability, value, or profitability of any particular portfolio or investment strategy. Neither we nor our affiliates will be liable for any errors or inaccuracies in the content, or for any actions you take based on that content. You expressly agree and acknowledge full responsibility for your use of the information contained in this press release.
To the extent permitted by applicable law, Refinitiv, its parent company, subsidiaries, affiliates, relevant shareholders, directors, officers, employees, agents, advertisers, content providers, and licensors (collectively, the 'Refinitiv Parties') shall not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive, or exemplary damages; This includes, but is not limited to, losses of profits, savings, or revenues, whether due to negligence, tort, contract, or other theories of liability, even if the parties to Refinitiv were advised of the possibility of any such damages or losses occurring or actually anticipated them.